TBI (Traumatic Brain Injury)STARSHIPNCT05688462
Studying Trends of Auto-Regulation in Severe Head Injury in Paediatrics
An observational study of TBI (Traumatic Brain Injury), run by Shruti Agrawal at 1 site in United Kingdom.
Trial summary
Children are known to have devastating impact from traumatic brain injury (TBI). The focus of treatment of severe TBI is to limit secondary insult which can aggravate brain injury and worsen outcome and is supported by monitoring brain pressure (ICP) and arterial pressure (ABP). Read more about this study
- Who is it for?
- Ages 3 months to 16 years
- Conditions the study is for
- TBI (Traumatic Brain Injury)
- What is being tested?
- Data Collection
- How many people
- 135 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Jul 2018to 31 Mar 2025
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 months to 16 years
- All sexes
- No healthy volunteers
- Child
Study population: Children upto the age of 16 years with TBI identified on CT/MRI with a clinical need for invasive blood pressure and intracranial pressure monitoring
Who may be able to join
- Patients 16 years old or younger at the time of injury
- Admitted to PICU for management of TBI
- TBI-related pathology confirmed on CT or MRI
- Clinical requirement for invasive monitoring of ICP and ABP
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
Children are known to have devastating impact from traumatic brain injury (TBI). The focus of treatment of severe TBI is to limit secondary insult which can aggravate brain injury and worsen outcome and is supported by monitoring brain pressure (ICP) and arterial pressure (ABP). These pressures, if incorporated in Multi-modality monitoring can be used to interpret state of mechanisms used by brain to maintain normal blood flow. This has been advised to guide management of severe TBI in adults, however, there is limited experience with advanced brain monitoring in children. The investigators propose to study the use of this in children with severe TBI. Children (up to 16 years of age) with a severe TBI are referred to a neurosurgical unit (NSU) and admitted to a paediatric intensive care unit (PICU) as part of usual NHS clinical practice. All patients with a severe TBI require a monitoring wire to be inserted into the brain to read the pressure inside the skull and a similar device in an artery to monitor the blood pressure. These recordings are documented by a PICU nurse at a prescribed frequency. Without interrupting this clinical practice investigators propose to record these values using computer software called ICM+. These recordings will provide real time analysis and a continual recording of important parameters which will provide the study with much needed information on the patterns of pressures in the brain after this injury in children. All patients will be followed up for 12 months to see how well they recover, neuropsychology assessment will be performed by a Neuropsychologist at the recruiting centre using a standardised form.
Read the detailed description
This is an observational prospective cohort study. Children admitted to ten identified PICUs in the UK with severe TBI with a clinical need for ICP and ABP monitoring are being included for data collection. The database will contain routinely monitored physiological parameters during management of PTBI in PICU. Without disturbing the routine care and management of these patients, investigators are collecting this data continuously in a bedside laptop equipped with the study software (ICM+, Cambridge Enterprise Ltd, Cambridge, UK). Alongside these physiological parameters, investigators are also collecting relevant clinical and demographic data (details below) and follow these patients for up to 12 months post ictus to assess neuro-psychological outcome. The created database will be used to analyze the state of cerebral autoregulation. Investigators will also analyze the data to see if investigators can derive optimal cerebral perfusion pressures based on the state of autoregulation and compare it with the patient outcome at 6 and 12 months. The database can also be subsequently used in the future projects testing hypotheses inspired by the experience gained in the adult TBI population research \& to answer important questions about severe PTBI.
Inclusion Criteria:
- Patients 16 years old or younger at the time of injury
- Admitted to PICU for management of TBI
- TBI-related pathology confirmed on CT or MRI
- Clinical requirement for invasive monitoring of ICP and ABP
Exclusion Criteria:
- None
Study Aim: The investigators aim to create a research database of high-resolution monitoring data from PTBI patients along with the clinical and demographic details and neuro-psychological outcome up to 12 months post-ictus, from 10 UK PICUs to be used for research purposes. As the first step, investigators analyze the data to determine retrospective optimal clinical parameters when managing these patients. The investigator's hypothesis is that investigators can define the optimal parameters for CPP based on indices of autoregulation (PRx) and that the optimal parameters of CPP and PRx in PTBI will differ to adults, both qualitatively and quantitatively.
Study Objectives:
Primary Objective: To detect thresholds of PRx associated with favourable outcome in PTBI.
Secondary objectives:
- Characterise patterns of optimal CPP in PTBI as a function of age, severity and character of injury, intracranial pressure, etc.
- Compare the fluctuations in these measured parameters with the outcome.
- Establish a comprehensive paediatric database of a basic set of high resolution (pulse waveforms resolution) neuro-monitoring data including ICP, ABP and ECG.
Patient Recruitment and Consent: Each PTBI patient admitted to the recruiting PICU with invasive monitoring of ICP and ABP is considered for recruitment. The research team at each recruiting PICU identifies the patients and sets up high-resolution data collection to the project laptop under an anonymised ID as soon as possible after the patient has been commenced on invasive monitoring and stabilized on PICU. Physiological and clinical data is recorded under this unique study ID. As the acute phase of the project is purely observational and does not involve any therapeutic intervention or change in regular standard care, investigators take a deferred consent for acute data collection and sharing. This is important to obtain a bias-free sample and ensure capture of early changes in intracranial physiology after head injury. When appropriate, the identified guardian/parent is informed and consented for data sharing and follow-up before the patient is discharged from the hospital. For patients who die before the consent can be obtained, the clinician in charge of patient's clinical care only (not study team) will access and anonymise data of the deceased patient under his/her clinical care; this anonymised data will then be provided to the study team.
Data Collection: ICP is monitored with an intraparenchymal microsensor inserted into the right (predominately but can be left) frontal cortex and ABP is monitored in the radial or femoral artery with a zero calibration at the level of the right atrium. The head end elevation is part of the standard international protocol for management for PTBI, and any deviations from this policy in individual cases will be recorded. Full resolution data of routinely monitored physiological parameters in managing PTBI [ICP, ABP, ETCO2, SpO2 and ECG] is collected from bed-side monitors. Pulsatile signals [ICP, ABP and ECG] are recorded with the maximum sampling frequency offered by the bed-side monitors, at least 100 Hz for invasive pressures, and at least 200Hz for ECG. This is done using relevant, monitor type specific, data export protocols implemented in the study (ICM+) software running on a bed-side laptop. The same software will be later used for the retrospective analysis of all stored signals. The continuous data collection is stopped when the patient either starts to wake up or dies and the invasive monitoring is stopped. Apart from general demographics and clinical data, the other data being collected are mechanism and details of injury, relevant past history, post resuscitation Glasgow coma scale, initial pupillary size and reactivity, pre-hospital hypoxia/ hypotension/ hyperthermia/ cardiopulmonary resuscitation, injury \& disease severity scores (Pediatric Index of Mortality- PIM II score, Injury Severity Score- ISS), CT scan findings. The investigators are also collecting: daily laboratory values (hemoglobin, glucose, sodium, lactate), PaO2, PaCO2 and FiO2, PEEP, medical interventions for TBI (positioning, collar, temperature, CO2, glucose, hypertonic saline or mannitol, sedation/paralysis, barbiturate coma, anti-seizure medication, use of vasoactive drugs to maintain blood pressure \& surgical interventions (haematoma evacuation, elevation of depressed fracture, CSF diversion-external ventricular drainage, new brain imaging, any other relevant event.
- Conditions
- TBI (Traumatic Brain Injury)
- Being tested
- Data Collection
- Medical subject headings
- Brain Injuries, Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Data CollectionOther
This is an observational prospective cohort study. Children admitted to ten identified PICUs in the UK with severe TBI with a clinical need for ICP and ABP monitoring will be included for data collection. The database will contain routinely monitored physiological parameters during management of PTBI in PICU. Without disturbing the routine care and management of these patients, investigators aim to collect this data continuously in a bedside laptop equipped with the study software (ICM+, Cambridge Enterprise Ltd, Cambridge, UK). Alongside these physiological parameters, investigators will also collect relevant clinical and demographic data (details below) and follow these patients for up to 12 months post ictus to assess neuro-psychological outcome.
What is being measured
The primary outcome is the main question the study is designed to answer.
To detect thresholds of PRx associated with favourable outcome in PTBI
Measured: 12 months
Secondary outcomes (3)
Characterise patterns of optimal CPP in PTBI as a function of age, severity and character of injury, intracranial pressure
Measured: 12 months
Compare the fluctuations in these measured parameters with the outcome.
Measured: 12 months
Establish a comprehensive paediatric database of a basic set of high resolution (pulse waveforms resolution) neuro-monitoring data including ICP, ABP and ECG
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jan 2023
- Study start1 Jul 2018
- Primary completion30 Apr 2024
- Study completion31 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for TBI (Traumatic Brain Injury)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 135 participants (actual)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Shruti Agrawal
- Sponsor type
- University, hospital or other
- Collaborators
- Action Medical Research
- Responsible party
- Sponsor-investigator, Shruti Agrawal, Cambridge University Hospitals NHS Foundation Trust
- Investigators
- Shruti Agrawal, MD, Principal investigator, Cambridge University Hospitals Nhs Foundation Trust - Cambridge, Cambridgeshire
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05688462
- Sponsor's protocol ID
- ADDENBROOKESHPTBI
- Acronym
- STARSHIP
- Status last verified
- May 2025
- First submitted
- 9 Jan 2023
- Last updated
- 7 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: On request. Data to be stored in a non-public secure reporsitory
Publications
Agrawal S, Smith C, Bogli SY, Placek MM, Cabeleira M, White D, Daubney E, Young A, Beqiri E, Kayani R, O'Donnell D, Pathan N, Watson S, Maw A, Ganrett M, Kanthimathinathan HK, Bangalore H, Sundararajan S, Subramanian G, Raffaj D, Sarfatti A, Lampareillo S, Mayer A, Ross O, Czosnyka M, Hutchinson PJ, Smielewski P; STARSHIP study team. Status of cerebrovascular autoregulation relates to outcome in severe paediatric head injury: STARSHIP, a prospective multicentre validation study. EClinicalMedicine. 2025 Feb 5;81:103077. doi: 10.1016/j.eclinm.2025.103077. eCollection 2025 Mar.
PubMed 39996125Agrawal S, Placek MM, White D, Daubney E, Cabeleira M, Smielewski P, Czosnyka M, Young A, Watson S, Maw A, Hutchinson PJ. Studying Trends of Auto-Regulation in Severe Head Injury in Paediatrics (STARSHIP): protocol to study cerebral autoregulation in a prospective multicentre observational research database study. BMJ Open. 2023 Mar 10;13(3):e071800. doi: 10.1136/bmjopen-2023-071800.
PubMed 36898758
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Studying Trends of Auto-Regulation in Severe Head Injury in Paediatrics
- ClinicalTrials.gov ID
- NCT05688462
- Acronym / sponsor ID
- STARSHIP / ADDENBROOKESHPTBI
- Conditions
- TBI (Traumatic Brain Injury)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 135 participants (actual)
- Lead sponsor
- Shruti AgrawalUniversity, hospital or other
- Collaborators
- Action Medical Research
- Study start
- 1 Jul 2018 (actual)
- Primary completion
- 30 Apr 2024 (actual)
- Study completion
- 31 Mar 2025 (actual)
- First posted
- 18 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Children are known to have devastating impact from traumatic brain injury (TBI). The focus of treatment of severe TBI is to limit secondary insult which can aggravate brain injury and worsen outcome and is supported by monitoring brain pressure (ICP) and arterial pressure (ABP). These pressures, if incorporated in Multi-modality monitoring can be used to interpret state of mechanisms used by brain to maintain normal blood flow. This has been advised to guide management of severe TBI in adults, however, there is limited experience with advanced brain monitoring in children. The investigators propose to study the use of this in children with severe TBI. Children (up to 16 years of age) with a severe TBI are referred to a neurosurgical unit (NSU) and admitted to a paediatric intensive care unit (PICU) as part of usual NHS clinical practice. All patients with a severe TBI require a monitoring wire to be inserted into the brain to read the pressure inside the skull and a similar device in an artery to monitor the blood pressure. These recordings are documented by a PICU nurse at a prescribed frequency. Without interrupting this clinical practice investigators propose to record these values using computer software called ICM+. These recordings will provide real time analysis and a continual recording of important parameters which will provide the study with much needed information on the patterns of pressures in the brain after this injury in children. All patients will be followed up for 12 months to see how well they recover, neuropsychology assessment will be performed by a Neuropsychologist at the recruiting centre using a standardised form.
Detailed description
This is an observational prospective cohort study. Children admitted to ten identified PICUs in the UK with severe TBI with a clinical need for ICP and ABP monitoring are being included for data collection. The database will contain routinely monitored physiological parameters during management of PTBI in PICU. Without disturbing the routine care and management of these patients, investigators are collecting this data continuously in a bedside laptop equipped with the study software (ICM+, Cambridge Enterprise Ltd, Cambridge, UK). Alongside these physiological parameters, investigators are also collecting relevant clinical and demographic data (details below) and follow these patients for up to 12 months post ictus to assess neuro-psychological outcome. The created database will be used to analyze the state of cerebral autoregulation. Investigators will also analyze the data to see if investigators can derive optimal cerebral perfusion pressures based on the state of autoregulation and compare it with the patient outcome at 6 and 12 months. The database can also be subsequently used in the future projects testing hypotheses inspired by the experience gained in the adult TBI population research \& to answer important questions about severe PTBI.
Inclusion Criteria:
- Patients 16 years old or younger at the time of injury
- Admitted to PICU for management of TBI
- TBI-related pathology confirmed on CT or MRI
- Clinical requirement for invasive monitoring of ICP and ABP
Exclusion Criteria:
- None
Study Aim: The investigators aim to create a research database of high-resolution monitoring data from PTBI patients along with the clinical and demographic details and neuro-psychological outcome up to 12 months post-ictus, from 10 UK PICUs to be used for research purposes. As the first step, investigators analyze the data to determine retrospective optimal clinical parameters when managing these patients. The investigator's hypothesis is that investigators can define the optimal parameters for CPP based on indices of autoregulation (PRx) and that the optimal parameters of CPP and PRx in PTBI will differ to adults, both qualitatively and quantitatively.
Study Objectives:
Primary Objective: To detect thresholds of PRx associated with favourable outcome in PTBI.
Secondary objectives:
- Characterise patterns of optimal CPP in PTBI as a function of age, severity and character of injury, intracranial pressure, etc.
- Compare the fluctuations in these measured parameters with the outcome.
- Establish a comprehensive paediatric database of a basic set of high resolution (pulse waveforms resolution) neuro-monitoring data including ICP, ABP and ECG.
Patient Recruitment and Consent: Each PTBI patient admitted to the recruiting PICU with invasive monitoring of ICP and ABP is considered for recruitment. The research team at each recruiting PICU identifies the patients and sets up high-resolution data collection to the project laptop under an anonymised ID as soon as possible after the patient has been commenced on invasive monitoring and stabilized on PICU. Physiological and clinical data is recorded under this unique study ID. As the acute phase of the project is purely observational and does not involve any therapeutic intervention or change in regular standard care, investigators take a deferred consent for acute data collection and sharing. This is important to obtain a bias-free sample and ensure capture of early changes in intracranial physiology after head injury. When appropriate, the identified guardian/parent is informed and consented for data sharing and follow-up before the patient is discharged from the hospital. For patients who die before the consent can be obtained, the clinician in charge of patient's clinical care only (not study team) will access and anonymise data of the deceased patient under his/her clinical care; this anonymised data will then be provided to the study team.
Data Collection: ICP is monitored with an intraparenchymal microsensor inserted into the right (predominately but can be left) frontal cortex and ABP is monitored in the radial or femoral artery with a zero calibration at the level of the right atrium. The head end elevation is part of the standard international protocol for management for PTBI, and any deviations from this policy in individual cases will be recorded. Full resolution data of routinely monitored physiological parameters in managing PTBI [ICP, ABP, ETCO2, SpO2 and ECG] is collected from bed-side monitors. Pulsatile signals [ICP, ABP and ECG] are recorded with the maximum sampling frequency offered by the bed-side monitors, at least 100 Hz for invasive pressures, and at least 200Hz for ECG. This is done using relevant, monitor type specific, data export protocols implemented in the study (ICM+) software running on a bed-side laptop. The same software will be later used for the retrospective analysis of all stored signals. The continuous data collection is stopped when the patient either starts to wake up or dies and the invasive monitoring is stopped. Apart from general demographics and clinical data, the other data being collected are mechanism and details of injury, relevant past history, post resuscitation Glasgow coma scale, initial pupillary size and reactivity, pre-hospital hypoxia/ hypotension/ hyperthermia/ cardiopulmonary resuscitation, injury \& disease severity scores (Pediatric Index of Mortality- PIM II score, Injury Severity Score- ISS), CT scan findings. The investigators are also collecting: daily laboratory values (hemoglobin, glucose, sodium, lactate), PaO2, PaCO2 and FiO2, PEEP, medical interventions for TBI (positioning, collar, temperature, CO2, glucose, hypertonic saline or mannitol, sedation/paralysis, barbiturate coma, anti-seizure medication, use of vasoactive drugs to maintain blood pressure \& surgical interventions (haematoma evacuation, elevation of depressed fracture, CSF diversion-external ventricular drainage, new brain imaging, any other relevant event.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 3 months to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Children upto the age of 16 years with TBI identified on CT/MRI with a clinical need for invasive blood pressure and intracranial pressure monitoring
Key inclusion criteria (4 listed)
- Patients 16 years old or younger at the time of injury
- Admitted to PICU for management of TBI
- TBI-related pathology confirmed on CT or MRI
- Clinical requirement for invasive monitoring of ICP and ABP
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Data CollectionThis is an observational prospective cohort study. Children admitted to ten identified PICUs in the UK with severe TBI with a clinical need for ICP and ABP monitoring will be included for data collection. The database will contain routinely monitored physiological parameters during management of PTBI in PICU. Without disturbing the routine care and management of these patients, investigators aim to collect this data continuously in a bedside laptop equipped with the study software (ICM+, Cambridge Enterprise Ltd, Cambridge, UK). Alongside these physiological parameters, investigators will also collect relevant clinical and demographic data (details below) and follow these patients for up to 12 months post ictus to assess neuro-psychological outcome. | Other | – |
Primary outcome
To detect thresholds of PRx associated with favourable outcome in PTBI
Time frame: 12 months
3 secondary outcomes
Characterise patterns of optimal CPP in PTBI as a function of age, severity and character of injury, intracranial pressure
Time frame: 12 months
Compare the fluctuations in these measured parameters with the outcome.
Time frame: 12 months
Establish a comprehensive paediatric database of a basic set of high resolution (pulse waveforms resolution) neuro-monitoring data including ICP, ABP and ECG
Time frame: 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2025.
- Background: PubMed 39996125Agrawal S, Smith C, Bogli SY, Placek MM, Cabeleira M, White D, Daubney E, Young A, Beqiri E, Kayani R, O'Donnell D, Pathan N, Watson S, Maw A, Ganrett M, Kanthimathinathan HK, Bangalore H, Sundararajan S, Subramanian G, Raffaj D, Sarfatti A, Lampareillo S, Mayer A, Ross O, Czosnyka M, Hutchinson PJ, Smielewski P; STARSHIP study team. Status of cerebrovascular autoregulation relates to outcome in severe paediatric head injury: STARSHIP, a prospective multicentre validation study. EClinicalMedicine. 2025 Feb 5;81:103077. doi: 10.1016/j.eclinm.2025.103077. eCollection 2025 Mar.
- Derived from this study: PubMed 36898758Agrawal S, Placek MM, White D, Daubney E, Cabeleira M, Smielewski P, Czosnyka M, Young A, Watson S, Maw A, Hutchinson PJ. Studying Trends of Auto-Regulation in Severe Head Injury in Paediatrics (STARSHIP): protocol to study cerebral autoregulation in a prospective multicentre observational research database study. BMJ Open. 2023 Mar 10;13(3):e071800. doi: 10.1136/bmjopen-2023-071800.
- Individual participant dataSharing planned: No. On request. Data to be stored in a non-public secure reporsitory
Related trials for TBI (Traumatic Brain Injury)
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
Enrolling by invitationPhase 1
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Mild Traumatic Brain Injury
RecruitingObservational study
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
Moderate Traumatic Brain Injury
Not yet recruitingPhase 1
Nanopulse Laser Therapy
TBI (Traumatic Brain Injury)
Recruiting
Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI)
Sleep Architecture, Mild Traumatic Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Shruti Agrawal, MD principal investigator
Cambridge University Hospitals Nhs Foundation Trust - Cambridge, Cambridgeshire
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of TBI (Traumatic Brain Injury), run by Shruti Agrawal at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To detect thresholds of PRx associated with favourable outcome in PTBI (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05688462, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2025.